Jonas Moecking

1.8k total citations · 1 hit paper
15 papers, 538 citations indexed

About

Jonas Moecking is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jonas Moecking has authored 15 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Oncology. Recurrent topics in Jonas Moecking's work include Inflammasome and immune disorders (7 papers), IL-33, ST2, and ILC Pathways (3 papers) and interferon and immune responses (2 papers). Jonas Moecking is often cited by papers focused on Inflammasome and immune disorders (7 papers), IL-33, ST2, and ILC Pathways (3 papers) and interferon and immune responses (2 papers). Jonas Moecking collaborates with scholars based in Germany, Australia and United States. Jonas Moecking's co-authors include Matthias Geyer, Gregor Hagelueken, Eicke Latz, Michael Pilsl, Rebecca Brinkschulte, Inga V. Hochheiser, Seth L. Masters, Christoph Engel, Chien‐Hsiung Yu and Ines H. Kaltheuner and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jonas Moecking

14 papers receiving 534 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3

2022 178 citations Inga V. Hochheiser, Michael Pilsl et al. Nature profile →

Peers

Jonas Moecking

MB

IMMUN

NEPHR

PHEOH

SURGE

Elsy M. Ngwa Switzerland

Elizabeth L. Orth-He United States

Akshay A. D’Cruz Australia

Yuxiang Huang United States

L. Michael Thomas United States

Qiangmin Zhang United States

Marija Pezer United States

Jorrit Boekel Sweden

C-T. Yuen United Kingdom

Gergely Imre Germany

Elsy M. Ngwa Switzerland

Jonas Moecking

553 ×1.2

MB

180 ×1.1

IMMUN

77 ×1.2

NEPHR

38 ×0.8

PHEOH

23 ×0.5

SURGE

Citations per year, relative to Jonas Moecking Jonas Moecking (= 1×) peers Elsy M. Ngwa

Countries citing papers authored by Jonas Moecking

Since Specialization

Citations

This map shows the geographic impact of Jonas Moecking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Moecking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Moecking more than expected).

Fields of papers citing papers by Jonas Moecking

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Moecking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Moecking. The network helps show where Jonas Moecking may publish in the future.

Co-authorship network of co-authors of Jonas Moecking

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Moecking. A scholar is included among the top collaborators of Jonas Moecking based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Moecking. Jonas Moecking is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Moecking, Jonas & Tzviya Zeev‐Ben‐Mordehai. (2025). Cryo-EM single-particle analysis expanding towards increasingly native samples. Acta Crystallographica Section D Structural Biology. 81(11). 587–597.

2.

Hagelueken, Gregor, et al.. (2023). Pyroptosis inhibiting nanobodies block Gasdermin D pore formation. Nature Communications. 14(1). 7923–7923. 14 indexed citations

3.

Schmitz, Maximilian, Ines H. Kaltheuner, K. Anand, et al.. (2023). The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation. Journal of Biological Chemistry. 300(1). 105501–105501. 6 indexed citations

4.

Jenster, Lea‐Marie, Sabine Normann, Jennifer Deborah Wuerth, et al.. (2022). P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection. The Journal of Experimental Medicine. 220(1). 67 indexed citations

5.

Rouillon, Christophe, Stefano Da Vela, Katrin Ackermann, et al.. (2022). Antiviral signalling by a cyclic nucleotide activated CRISPR protease. Nature. 614(7946). 168–174. 30 indexed citations

6.

Moecking, Jonas, Pawat Laohamonthonkul, Gregor Hagelueken, et al.. (2022). Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domain. Journal of Biological Chemistry. 298(12). 102645–102645. 6 indexed citations

7.

Hochheiser, Inga V., Michael Pilsl, Gregor Hagelueken, et al.. (2022). Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature. 604(7904). 184–189. 178 indexed citations breakdown →

8.

Peter, M., Emmanuele Severi, Jonas Moecking, et al.. (2022). Structural and mechanistic analysis of a tripartite ATP-independent periplasmic TRAP transporter. Nature Communications. 13(1). 4471–4471. 20 indexed citations

9.

Moecking, Jonas & Matthias Geyer. (2022). A Surface Plasmon Resonance-Based Strategy to Characterize Interactions of NLR Proteins with Associated Factors. Methods in molecular biology. 2523. 161–177. 1 indexed citations

10.

Kaltheuner, Ines H., K. Anand, Jonas Moecking, et al.. (2021). Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. Nature Communications. 12(1). 6607–6607. 24 indexed citations

11.

Steiner, Annemarie, Alessandra Pontillo, Isabella Ceccherini, et al.. (2021). Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus. Journal of Clinical Immunology. 42(2). 325–335. 23 indexed citations

12.

Moecking, Jonas, Pawat Laohamonthonkul, Marquitta J. White, et al.. (2020). NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity. Journal of Allergy and Clinical Immunology. 147(6). 2134–2145.e20. 15 indexed citations

13.

Yu, Chien‐Hsiung, Jonas Moecking, Matthias Geyer, & Seth L. Masters. (2017). Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice. Journal of Molecular Biology. 430(2). 142–152. 71 indexed citations

14.

Hart‐Smith, Gene, et al.. (2015). Yeast proteins Gar1p, Nop1p, Npl3p, Nsr1p, and Rps2p are natively methylated and are substrates of the arginine methyltransferase Hmt1p. PROTEOMICS. 15(18). 3209–3218. 31 indexed citations

15.

Trenholme, Katharine R., Linda Marek, Sandra Duffy, et al.. (2014). Lysine Acetylation in Sexual Stage Malaria Parasites Is a Target for Antimalarial Small Molecules. Antimicrobial Agents and Chemotherapy. 58(7). 3666–3678. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact